News
23h
TipRanks on MSNBioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer
The intervention being tested is BNT323/DB-1303, an investigational drug administered via intravenous infusion. It is compared against standard chemotherapy options, doxorubicin or paclitaxel, chosen ...
The Canadian Press on MSN19h
Health Canada approves updated Pfizer, Moderna COVID-19 vaccines for fall
TORONTO — Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this ...
23h
Zacks.com on MSNBMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?
Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.
Provinces and territories are responsible for deciding who will get free vaccines. Saskatchewan govt. says "information about the fall dose of the COVID-19 vaccine will be available this fall." ...
A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results